Abstract
Summarizing >1000 PowerPoint slides and hours of presentations, punctuated with lively discussions, has led to consensus and conclusions from this landmark meeting. The Steering Committee has charted a new roadmap for discovery and treatment of ESRD, particularly focused on dialysis modalities. Statements, some bold and paradigm-shifting in character, will serve as the legacy for this seminal gathering of highly experienced experts, fully attuned to the realties of present day care of dialysis patients in the United States and the world. The original mission of the meeting was to analyze the two decades of caring for patients with ESRD (by HD and PD dialysis) that have transpired since the landmark Dallas ESRD meeting of 1989 to determine our progress. If progress was found wanting, the mission was to outline what we must do to correct the errors of the past and move forward under a new strategy of care. As this document attests, this goal was achieved. Before proceeding with the summary of the meeting and deriving conclusions, the Steering Committee expresses its sincere appreciation to the American Society of Nephrology, European Dialysis and Transplant Association/European Renal Association, International Society of Nephrology, National Kidney Foundation, and the Renal Physicians Association for their support and for endorsing the meeting and to the sponsors mentioned at the beginning of this supplement for their financial support. Without either, this meeting would not have received the international recognition that it even already has received. The background, the prevailing milieu, in which this has occurred, is very important. The setting must be understood if we are going to introduce new scientific information that will dictate innovative models of care. We focus here on the facts that pertain to the United States:
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call